SciLifeLab National COVID-19 Research Program

The purpose of the national program is to provide useful knowledge about the corona pandemic, both now and in the case of future pandemics, to improve preventions, diagnostics and treatments of viral disease, provide a clearer real-time overview of the pandemic, integrate data across technologies and research domains, and create better predictive models. 

Program Directors: Olli Kallioniemi, Karolinska Institutet and Mia Phillipson, Uppsala University (also members of SciLifeLab Management Group)

Program Coordinators: Disa L. Hammarlöf, KTH Royal Institute of Technology, and Alice Sollazzo, Uppsala University (also members of SciLifeLab Operations Office).

Continuation of program

With support from KAW, the SciLifeLab National COVID-19 Research Program has been extended until 2022. We welcome input and ideas from the SciLifeLab community on how to best continue the program. Please submit your feedback to: 
covid19-calls@scilifelab.se.


67 projects in nine areas

Launched through an open call for proposals, the program contains 67 projects within nine research areas, studying COVID-19 at the molecular, cellular, patient, population and environmental level.

To enable synergies, the projects will be connected to each other, leverage the SciLifeLab infrastructure, and contribute to open data as well as the national COVID-19 data portal. The projects are funded with a total of 50 MSEK from Knut and Alice Wallenberg Foundation. In addition, the SciLifeLab board has decided to allocate 12 MSEK of national SciLifeLab funding, for coordinating the program and connecting it with the SciLifeLab infrastructure. The national funding has now been utilized to, among other things, fund a call for needs within the program.

Each research area has been appointed a scientific lead and coordinator, who promote collaboration and data sharing within the area, and help to form links within the entire program, and to SciLifeLab’s infrastructure, data management support and the COVID-19 program management.

Quick links

Background

National funding to support research area needs

Description of SciLifeLab National COVID-19 Research Program

Information for Principal Investigators

News articles

National funding to strengthen the collaborative environment of SciLifeLab’s COVID-19 research program (SciLifeLab News)

Sharing knowledge and setting up collaborations in the next phase of SciLifeLab’s COVID-19 program (SciLifeLab News)

The SciLifeLab national COVID-19 research program receives an additional MSEK 50 from KAW (SciLifeLab News)

Combating COVID-19 Webinar: The story so far and the future of COVID-19 research (SciLifeLab News)

Research areas

Biobanks for COVID-19 research

Read more

Diagnostics for virus

Read more

Viral sequence evolution

Read more

High-throughput and high-content serology

Read more

Biomarkers and systems immunology

Read more

Host cell systems biology and targets

Read more

Drug discovery and repurposing of drugs

Read more

Environmental virus profiling

Read more

Data-driven research – models and AI

Read more

Background

In March 2020, SciLifeLab launched a national call for researchers nationwide, to create a comprehensive program to combat the coronavirus pandemic. A total of 285 proposals were submitted, with applicants ranging from several Swedish universities and hospitals, and other organizations both in Sweden and abroad. The SciLifeLab management group and experts in the field reviewed all proposals and approved 67 for funding.

The projects will be funded with a total of 50 MSEK from Knut and Alice Wallenberg Foundation. Furthermore, the SciLifeLab board has allocated 12 MSEK for coordination of the program and connecting it with the SciLifeLab infrastructure, to further strengthen the effects of the initiative.

Besides scientific impact, the evaluation criteria considered were relevance and impact on tackling the COVID-19 pandemic, opportunities created by the SciLifeLab community, possibility to form synergies and collaborations, commitment to open data and real-time updates of progress.


Read more about the call and evaluation process

Proportions of each research area.



National funding to support research area needs

To further promote a strong and collaborative research environment within the COVID-19 program, and ensure that the participants have the resources required to conduct their COVID-19 related research at full speed, a program-specific call was launched in June 2020. The focus of the call was infrastructure needs, and conditions that need to be met in order to form capabilities between research areas and SciLifeLab facilities.

The call mainly addressed the most urgent and critical needs, to get the projects up-and-running. Need inventories were formulated by scientific leads, coordinators and PIs representing five of the nine research areas, and after a review by the program management and SciLifeLab Infrastructure Director, national funding was decided to support the following needs:

  • Biobanks for COVID-19 research
    Support for coordination and biobanking
  • High-throughput and high-content serology
    Support for data analysis and logistics
  • Host cell systems biology and targets
    Support for BSL3 facility to enable access and services for COVID-19 research
  • Drug discovery and repurposing of drugs
    Support for database build up and compound center support
  • Environmental virus profiling
    Support for infrastructure required to rapidly create a national support function for biobanking of environmental samples for virus monitoring  (initially waste water)
  • Data Centre
    Support for data management for the SciLifeLab COVID-19 program

The funding will amount to a total of 4,4 MSEK, of which 1 MSEK will be allocated to data management support for the program. 

A second call, focused on more long-term infrastructure needs and possible new capabilities, was launched in August, allowing more time for discussions of solutions and possibilities between research areas and SciLifeLab platforms and collaborators. 6.4 MSEK national funding was decided to support:

  • Biobanks for COVID-19 research
    Support to ensure sample quality and adequate sample collection capabilities
  • High-throughput and high-content serology
    Development of Cross-facility Capability related to epitope mapping
  • Drug discovery and repurposing of drugs
    Maintenance of the chemistry-centric data portal for COVID-19 and development of capabilities in ChemoInformatics and Computational chemistry
  • Environmental virus profiling
    Establishing a national resource dedicated to environmental monitoring of infectious agents, an environmental virus biobank and capability for environmental virus profiling at SciLifeLab
  • Data Centre
    Support for data management for the SciLifeLab COVID-19 program
  • COVID-19 program sequencing capability
    Support of coordination of environmental and COVID-19 samples, and build-up of long-term capability for Environmental virus profiling
  • Upgrade of SciLifeLab facilities to biosafety laboratory BSL2 standard


Description of SciLifeLab National COVID-19 Research Program

This document describes the background of SciLifeLab:s national COVID-19 program. It outlines program milestones, sets the framework for how the research program is structured and how it operates, through connections to the infrastructure, Data Centre and other SciLifeLab functions. Follow-up reports will describe the results of the program.

Program descriptionDownload
Program description – appendicesDownload

Information for Principal Investigators

Funding acknowledgement

Funding through the SciLifeLab National COVID-19 Research Program should be acknowledged as This study was supported by grants to Science for Life Laboratory from the Knut and Alice Wallenberg Foundation (2020.0182).

Project financial reporting

Please find below the deadlines for sending the financial reports and requisition regarding KAW-grants for COVID-19 to Marika Kokk, KTH. For this purpose, please use the KAW-requisition template and enclose documentation for the costs, such as extracts from the general ledger.

All costs regarding 2020 must be submitted by email by 31st of January 2021.
All costs regarding 2021 must be submitted by email by 31st of January 2022.

Please note that costs that have not been reported by the second, final deadline for this project, cannot be reimbursed.

KAW-requisition template:Download

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT